Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Immunotherapy
Clinical Trials
Breast Cancer
Multiple Myeloma
PARP Inhibitors
Antibody-Drug Conjugates
Colorectal Cancer
Chronic Lymphocytic Leukemia
Ovarian Cancer
Endometrial Cancer
Prostate Cancer
Metastatic Breast Cancer
Chemotherapy
Acute Myeloid Leukemia
Pembrolizumab
Circulating Tumor DNA
CAR T-Cell Therapy
BTK Inhibitors
Non-Small Cell Lung Cancer
Venetoclax

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes485Founded6 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Featuring perspectives from Dr David H Ilson and Dr Kohei Shitara, including the following topics:

• Introduction (00:00)

• Biomarker Evaluation in Localized and Metastatic Disease (1:49)

• Role of Immune Checkpoint Inhibitors in the Management of G... more

YouTube

Featuring perspectives from Dr Rahul Aggarwal, Dr Matthew D Galsky and Dr Tian Zhang, including the following topics:

• Introduction: Welcome GU Oncology Fellows! (0:00)

• Prostate Cancer — Dr Aggarwal (12:48)

• Urothelial Bladder Cancer — Dr Galsky... more

YouTube

Featuring perspectives from Prof Yohann Loriot, including the following topics:

• Case: A man in his early 80s with metastatic urothelial bladder cancer (mUBC) receives enfortumab vedotin (EV)/pembrolizumab but experiences immune-related adverse eve... more

YouTube

Featuring perspectives from Ms Blanca Ledezma, Dr Marissa Marti-Smith, Dr Heather McArthur and Dr Ruth M O'Regan, moderated by Dr McArthur, including the following topics:

• Introduction (0:00)

• Current Clinical Role of Oral Selective Estrogen Rece... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Susmita Apuri
General medical oncologist presenting cases
Mass General Cancer Center (case presenter)
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Dr Bita Fakhri
Bita Fakhri
Stanford University School of Medicine
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Dr Ma
Shuo Ma, Clinical oncologist
Northwestern University
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Priya Rudolph
General medical oncologist presenting cases
Stanford University School of Medicine
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Steven Fred Divers
General medical oncologist presenting cases
Northwestern Medicine
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Dr John Allan
John Allan
Weill Cornell Medicine
Episode: Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Maurice Pérol
Faculty presenter, Léon-Bérard Center
Léon-Bérard Center
Episode: Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
John Heymach
Faculty presenter, University of Texas, MD Anderson Cancer Center
University of Texas MD Anderson Cancer Center
Episode: Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
Dr Bradley Monk
Gynecologic oncologist, ADC-focused clinician
Episode: TROP2- and CDH6-Directed ADCs in Gynecologic Cancers — An Interview with Dr Ramez Eskander on Key Presentations from the Society of Gynecologic Oncology 2026 Annual Meeting

Host

Neil Love
Host of the program; multiple instances across Oncology Today series

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#171
South Korea/Science
Apple Podcasts
#208
Brazil/Science
Apple Podcasts
#237
Saudi Arabia/Science
Apple Podcasts
#244
India/Science

Talking Points

Recent interactions between the hosts and their guests.

HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2
Q: What are the most compelling reasons to shift HER2-mutant NSCLC toward frontline targeted therapy with Zongurtinib?
Frontline data show very high response rates and durable disease control with Zongurtinib, often outperforming chemotherapy regimens, and the safety profile remains manageable, prompting consideration of moving these patients earlier in the treatment sequence.
Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Q: What is the role of PD-L1 status in selecting ADCs vs. immunotherapy combinations?
PD-L1 status informs whether immunotherapy is likely to add benefit, particularly in combinations like SG with pembrolizumab; however, some ADCs (e.g., certain TROPO2 agents) show activity regardless of PD-L1, and ongoing trials are clarifying when to prioritize ADCs alone vs. in combination with IO.
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
Q: Why might intermittent therapy be considered, and how does EMBARQ inform its real-world application?
Intermittent therapy relies on cycles of treatment and off periods guided by PSA and response; EMBARQ demonstrated a meaningful off period only in extreme responders with centralized PSA monitoring, suggesting careful patient selection and real-world variability in practice.
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
Q: What is the MOA difference between androgen receptor agonists and antagonists in ADT, and how does that translate into endocrine profiles?
Antagonists block the GnRH receptor, causing a rapid and deeper drop in LH/FSH and testosterone, whereas agonists initially stimulate the axis and then cause a rebound followed by suppression; this yields different endocrine dynamics and potentially different cardiovascular implications.
Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
Q: What happened to the patient who received induction therapy with carboplatin, paclitaxel, and nivolumab?
The patient had a strong tumor and nodal response but developed hypothyroidism; after three cycles, the treatment was halted due to toxicity concerns and planning around surgery.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

A clinically oriented show featuring medical oncologists and cancer researchers discussing new research, treatment strategies, and practical applications for general oncology practice. Episodes commonly center on hematologic and solid tumor malignancies, with deep dives into frontline versus relapse options, sequencing of therapies, adverse event management, and emerging modalities such as MRD-guided decisions, fixed-duration regimens, and novel agents (including BTK inhibitors, venetoclax-based regimens, HER2-targeted therapies, and cell/immune-based approaches). Guests frequently come from major academic centers and cancer institutes, bringing case-based perspectives, trial context, and real-world considerations to help practicing oncolog... more

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Two Onc Docs
2. Research To Practice | Oncology Videos
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. Gastrointestinal Cancer Update
5. OncLive® On Air

How many episodes of Oncology Today are there?

Oncology Today launched 6 years ago and published 485 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Susmita Apuri
2. Dr Bita Fakhri
3. Dr Ma
4. Priya Rudolph
5. Steven Fred Divers
6. Dr John Allan
7. Maurice Pérol
8. John Heymach

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days